Elevated cerebrospinal fluid and serum YKL-40 levels are not associated with symptomatic vasospasm in patients with aneurysmal subarachnoid haemorrhage

Journal of Clinical Neuroscience

Volumn 15, Issue 9, 2008, Pages 1011-1016

  Kacira, Tibet ^a   Hanimoglu, Hakan ^a   Kucur, Mine ^a   Sanus, Galip Zihni ^a   Kafadar, Ali Metin ^a   Tanriverdi, Taner ^a   Kaynar, Mehmet Yasar ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Aneurysm; Inflammation; Subarachnoid haemorrhage; Vasospasm; YKL 40

Indexed keywords

MATRIX PROTEIN; PROTEIN YKL 40;

ADULT; AGED; ARTICLE; BRAIN ARTERY ANEURYSM; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GLASGOW COMA SCALE; HUMAN; HYDROCEPHALUS; MALE; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; VASOSPASM;

ADULT; AGED; BIOLOGICAL MARKERS; CEREBRAL ARTERIES; ENCEPHALITIS; FEMALE; GLYCOPROTEINS; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SUBARACHNOID HEMORRHAGE; SUBARACHNOID SPACE; TIME FACTORS; UP-REGULATION; VASOSPASM, INTRACRANIAL;

EID: 48449096280     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2006.11.014     Document Type: Article

References (34)

1. Sonobe M., and Suzuki J. Vasospasmogenic substance produced following subarachnoid hemorrhage, and its fate. Acta Neurochir 44 (1978) 97-106
2. Kaynar M.Y., Tanriverdi T., Kafadar A.M., et al. Detection of soluble intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in both cerebrospinal fluid and serum of patients after aneurysmal subarachnoid hemorrhage. J Neurosurg 101 (2004) 1030-1036
3. Kaynar M.Y., Tanriverdi T., Kemerdere R., et al. Cerebrospinal fluid superoxide dismutase and serum malondialdehyde levels in patients with subarachnoid hemorrhage: Preliminary results. Neurol Res 27 (2005) 562-567
4. Uzun H., Tanriverdi T., Kafadar A.M., et al. Oxidized low-density lipoprotein and paraoxonase levels in matched serum and cerebrospinal fluid from patients with aneurysmal subarachnoid hemorrhage: Preliminary results. Nepal J Neurosci 2 (2005) 129-133
5. Tanriverdi T., Sanus G.Z., Ulu M.O., et al. Detection of soluble E-selectin in both cerebrospinal fluid and serum of patients after aneurysmal subarachnoid haemorrhage. Braz J Med Biol Res 38 (2005) 1703-1710
6. Borregaard N., and Cowland J.B. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 89 (1997) 3503-3521
7. Johansen J.S., Williamson M.K., Rice J.S., et al. Identification of proteins secreted by human osteoblastic cells in culture. J Bone Miner Res 7 (1992) 501-512
8. Rehli M., Ammon C., Langmann S., et al. Transcriptional regulation of CHI3L1, a marker gene for late stages of macrophage differentiation. J Biol Chem 278 (2003) 44058-44067
9. Nordenbaek C., Johansen J.S., Junker P., et al. YKL-40, a matrix protein of specific granules in neutrophils, is elevated in serum of patients with community-acquired pneumonia requiring hospitalization. J Infect Dis 180 (1999) 1722-1726
10. Conrozier T., Carlier M.-C., Mathieu P., et al. Serum levels of YKL-40 and C-reactive protein in patients with hip osteoarthritis and healthy subjects: a cross sectional study. Ann Rheum Dis 59 (2000) 828-831
11. Østergaard C., Johansen J.S., Benfield T., et al. YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis. Clin Diag Lab Immunol 9 (2002) 598-604
12. Renkema G.H., Boot R.G., Au F.L., et al. Chitotriosidase, a chitinase, and the 39-kDa human cartilage glycoprotein, a chitin-binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages. Eur J Biochem 251 (1998) 504-509
13. Hakala B.E., White C., and Recklies A.D. Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 268 (1993) 25803-25810
14. Johansen J.S., Christofferson P., Mǿller S., et al. Serum YKL-40 is increased in patients with hepatic fibrosis. J Hepatol 32 (2000) 911-920
15. Volck B., Johansen J.S., Stoltenberg M., et al. Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology. Osteoarthritis Cartilage 9 (2001) 203-214
16. Peltomaa R., Paimela L., Harvey S., et al. Increased level of YKL-40 in sera from patients with early rheumatoid arthritis: a new marker for disease activity. Rheumatol Int 20 (2001) 192-196
17. Johansen J.S., Kirwan J.R., Price P.A., et al. Serum YKL-40 concentrations in patients with early rheumatoid arthritis: relation to joint destruction. Scand J Rheumatol 30 (2001) 297-304
18. Cintin C., Johansen J.S., Christensen I.J., et al. High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival. Cancer 95 (2002) 267-274
19. Kronborg G., Østergaard C., Weis N., et al. Serum level of YKL-40 is elevated in patients with streptococcus pneumoniae bacteremia and is associated with the outcome of the disease. Scand J Infect Dis 34 (2002) 323-326
20. Koutroubakis I.E., Petinaki E., Dimoulis P., et al. Increased serum levels of YKL-40 in patients with inflammatory bowel disease. Int J Colorectal Dis 18 (2003) 254-259
21. Johansen J.S., Christensen J., Riisbro R., et al. High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival. Breast Cancer Res Treat 80 (2003) 15-21
22. Nǿjgaard C., Johansen J.S., Christensen E., et al. Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease. J Hepatol 39 (2003) 179-186
23. Vind I., Johansen J.S., Price P.A., et al. Serum YKL-40, a potential new marker of disease activity in patients with inflammatory bowel disease. Scand J Gastroenterol 6 (2003) 599-605
24. Johansen J.S., Drivsholm L., Price P.A., et al. High serum YKL-40 level in patients with small cell lung cancer is related to early death. Lung Cancer 46 (2004) 333-340
25. Dupont J., Tanwar M.K., Thaler H.T., et al. Early detection and prognosis of ovarian cancer using serum YKL-40. J Clin Oncol 22 (2004) 3330-3339
26. Johansen J.S., Milman N., Hansen M., et al. Increased serum YKL-40 in patients with pulmonary sarcoidosis: a potential marker of disease activity. Respiratory Med 99 (2005) 396-402
27. Nordenbaek C., Johansen J.S., Halberg P., et al. High serum levels of YKL-40 in patients with systemic sclerosis are associated with pulmonary involvement. Scand J Rheumatol 34 (2005) 293-297
28. Schmidt H., Johansen J.S., Gehl J., et al. Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma. Cancer 106 (2006) 1130-1139
29. Kaynar M.Y., Tanriverdi T., Kafadar A.M., et al. YKL-40 Levels in the cerebrospinal fluid and serum of patients with aneurysmal subarachnoid hemorrhage: Preliminary Results. J Clin Neurosci 12 (2005) 754-757
30. Tanwar M.K., Gilbert M.R., and Holland E.C. Gene expression microarray analysis reveals YKL-40 to be potential serum marker for malignant character in human glioma. Cancer Res 62 (2002) 4364-4368
31. Tsuji T., Matsuyama Y., Natsume N., et al. Analysis of chondrex (YKL-40, HC gp-39) in the cerebrospinal fluid of patients with spine disease. Spine 27 (2002) 732-735
32. De Ceuninck F., Gaufillier S., Bonnaud A., et al. YKL-40 (cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes. Biochem Biophys Res Commun 285 (2001) 926-931
33. Malinda K.M., Ponce L., Kleinman H.K., et al. Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells. Exp Cell Res 250 (1999) 168-173
34. Volck B., Price P.A., Johansen J.S., et al. YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils. Proc Assoc Am Physicians 110 (1998) 351-360